The first healthcare provider to be found liable in one of several underpayments class actions by junior doctors is challenging a ruling that found permission to work overtime hours did not have to be expressly given.
Indian generic drug maker Cipla has sued pharmaceutical giants Bristol-Myers Squibb and Pfizer alleging the patents behind their blockbuster deep vein thrombosis drug Eliquis are invalid.
Sydney-based plastic surgeon Daniel Lanzer, who is facing a class action by 1,000 former patients, has been hit with a new lawsuit alleging he performed a negligent liposuction and fat transfer procedure, which left a woman with disfigurement, necrosis and nerve damage.
The runner-up in a contest to administer Johnson & Johnson’s $300 million settlement of two pelvic mesh class actions has lost a challenge to a decision awarding the prize to the team of Slater & Gordon, BDO and the firm of former Shine Lawyers solicitor Jan Saddler.
A group of surgeons who worked for The Cosmetic Institute are appealing a judge’s rejection of their bid to declass a representative proceeding on behalf of 13,500 patients who claim they suffered injury or complications from breast augmentation surgery.
A judge has approved a bid to consolidate two shareholder class actions against Medibank over a cyberattack that affected 10 million customers, finding that having two firms on the record is better than a carriage contest.
A patient who gave his plastic surgeon a one-star review for a nose job is challenging a judgment that put him on the hook for $50,000 in defamation damages.
A 16-year battle between the federal government and drug maker Sanofi-Aventis over an allegedly unjustified court order that prevented the release of a generic version of blockbuster blood-thinner Plavix has gone to the High Court.
A judge has endorsed Medibank’s bid to sue the OAIC so the court can weigh in on the health insurer’s bid to halt the regulator’s investigation in favour of a class action over its October data breach, saying the OAIC’s interference with the court proceedings could constitute a contempt of court.
A judge has approved a $41.45 million settlement in a pelvic mesh class action against manufacturers Covidien and TFS but has put off deciding on the costs of the firm that ran the case, saying it is “next to useless” when law firms appoint their own costs consultants.